Technical Analysis for LIFE - aTyr Pharma, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Support | Bullish | 0.00% | |
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| Earnings Movers | Other | 0.00% | |
| Outside Day | Range Expansion | 0.00% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -0.59% | |
| Bollinger Band Squeeze | Range Contraction | -0.59% | |
| Earnings Movers | Other | -0.59% | |
| Inside Day | Range Contraction | -0.59% | |
| Gapped Up | Strength | -0.59% | |
| Up 3 Days in a Row | Strength | -0.59% |
| Alert | Time |
|---|---|
| 20 DMA Support | about 10 hours ago |
| Outside Day | about 10 hours ago |
| Down 3% | about 10 hours ago |
| Non-ADX 1,2,3,4 Bearish Retracement Entry | about 10 hours ago |
| Fell Below Previous Day's Low | about 10 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/07/2024
aTyr Pharma, Inc. engages in the discovery and clinical development of protein based therapeutics for patients suffering from severe and rare diseases. The company is developing Resolaris, which is in Phase Ib/II clinical trials in adult patients with facioscapulohumeral muscular dystrophy, a rare genetic myopathy with an immune component. Its products pipeline also includes Resolaris for treatment of patients with early onset facioscapulohumeral muscular dystrophy, a rare genetic myopathy with an immune component and limb-girdle muscular dystrophies, as well as rare pulmonary diseases with an immune component. In addition, the company is developing iMod.Fc, a preclinical immuno-modulatory domain program. The company was founded in 2005 and is headquartered in San Diego, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Organ Systems Clinical Development Rare Diseases Dystrophy Muscular Dystrophy Pulmonary Disease Myopathy Musculoskeletal System Severe And Rare Diseases Facioscapulohumeral Muscular Dystrophy Muscular Dystrophies Limb Girdle Muscular Dystrophies
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Organ Systems Clinical Development Rare Diseases Dystrophy Muscular Dystrophy Pulmonary Disease Myopathy Musculoskeletal System Severe And Rare Diseases Facioscapulohumeral Muscular Dystrophy Muscular Dystrophies Limb Girdle Muscular Dystrophies
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 2.695 |
| 52 Week Low | 1.0801 |
| Average Volume | 529,219 |
| 200-Day Moving Average | 1.60 |
| 50-Day Moving Average | 1.75 |
| 20-Day Moving Average | 1.63 |
| 10-Day Moving Average | 1.62 |
| Average True Range | 0.09 |
| RSI (14) | 50.98 |
| ADX | 17.11 |
| +DI | 19.55 |
| -DI | 15.73 |
| Chandelier Exit (Long, 3 ATRs) | 1.61 |
| Chandelier Exit (Short, 3 ATRs) | 1.80 |
| Upper Bollinger Bands | 1.74 |
| Lower Bollinger Band | 1.52 |
| Percent B (%b) | 0.76 |
| BandWidth | 13.35 |
| MACD Line | -0.03 |
| MACD Signal Line | -0.05 |
| MACD Histogram | 0.017 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.83 | ||||
| Resistance 3 (R3) | 1.82 | 1.77 | 1.80 | ||
| Resistance 2 (R2) | 1.77 | 1.74 | 1.77 | 1.79 | |
| Resistance 1 (R1) | 1.73 | 1.71 | 1.75 | 1.74 | 1.79 |
| Pivot Point | 1.68 | 1.68 | 1.69 | 1.68 | 1.68 |
| Support 1 (S1) | 1.64 | 1.65 | 1.66 | 1.65 | 1.59 |
| Support 2 (S2) | 1.59 | 1.62 | 1.59 | 1.59 | |
| Support 3 (S3) | 1.55 | 1.59 | 1.58 | ||
| Support 4 (S4) | 1.56 |
